You are here

  • Home
  • Archive
  • Volume 12, Issue 1
  • Cell membrane-anchored and tumor-targeted IL-12 T-cell therapy destroys cancer-associated fibroblasts and disrupts extracellular matrix in heterogenous osteosarcoma xenograft models

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Cell membrane-anchored and tumor-targeted IL-12 T-cell therapy destroys cancer-associated fibroblasts and disrupts extracellular matrix in heterogenous osteosarcoma xenograft models

 

Online download statistics by month:

Online download statistics by month: January 2024 to September 2025

AbstractFullPdf
Jan 2024800806344
Feb 2024633641196
Mar 2024342348135
Apr 202417818468
May 202412612875
Jun 202414114589
Jul 202410110158
Aug 202411811657
Sep 202411912264
Oct 202410510968
Nov 202414314491
Dec 202413714473
Jan 202512812876
Feb 2025299299198
Mar 2025126126215
Apr 2025112113120
May 2025102102120
Jun 2025515259
Jul 2025110
Sep 2025220
Total376438112106